Management of Patients With Atrial Fibrillation

Publication Date: November 30, 2023
Last Updated: April 4, 2024

Introduction

2.5. Addressing Health Inequities and Barriers to AF Management

1. Patients with AF, regardless of sex and gender diversity, race and ethnicity, or adverse social determinants of health (SDOH),* should be equitably offered guideline-directed stroke risk reduction therapies as well as rate or rhythm control strategies and LRFM as indicated to improve QOL and prevent adverse outcomes. (1, B-NR)
* Including lower income, lower education, inadequate or lack of insurance coverage, or rurality.
3594638

Management

4.2. Basic Evaluation

4.2.1. Basic Clinical Evaluation

1. In patients with newly diagnosed AF, a transthoracic echocardiogram to assess cardiac structure, laboratory testing to include a complete blood count, metabolic panel, and thyroid function, and testing to assess for other medical conditions associated with AF are recommended to determine stroke and bleeding risk factors, as well as underlying conditions that will guide further management. (1, B-NR)
3594638

Overview

Title

Management of Patients With Atrial Fibrillation

Authoring Organizations